Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
基本信息
- 批准号:10561701
- 负责人:
- 金额:$ 70.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistBindingBiological ProcessCardiovascular DiseasesCell NucleusCell ProliferationCell SurvivalCell membraneCell physiologyCytosolDNA RepairDiabetes MellitusDiagnosticDiseaseEGF geneEndosomesEpidermal Growth Factor ReceptorEventGene ExpressionGenerationsGenesImmune System DiseasesLinkMAP4Malignant NeoplasmsMembraneMicrotubulesNeurodevelopmental DisorderNeuronsNuclearOutcomePDPK1 genePIK3CG genePTEN genePathway interactionsPhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphotransferasesPolymeraseProcessProtein DephosphorylationRegulationResearchResistanceRoleSecond Messenger SystemsSignal PathwaySignal TransductionStressSystemTP53 geneTherapeuticTumor Suppressor Proteinsbiological adaptation to stresscancer cellinorganic phosphateinositol polyphosphate multikinasenovelreceptorscaffold
项目摘要
PROJECT SUMMARY. This research seeks to understand spatial phosphoinositide signaling (PI) mechanisms
in the cytosol and nucleus. These pathways have broad implications for cancer, neurodevelopmental disorders,
diabetes, and several congenital diseases. In the cytosol, agonists, such as EGF (and many others), activate
signaling pathways that control most cellular functions. In the nucleus, these pathways are separate from known
membrane compartments but control stress responses that impact DNA repair, cell survival, and other events.
Agonists activated PI3K signaling occurs through the IQGAP1 scaffold that assembles multiple pathways
including the PI 3-kinase and Erk pathways. Yet, how the IQGAPs assemble specific signaling pathways is not
understood. We will focus on the assembly of the full PI 3-kinase pathway on IQGAPs. This includes the
assembly of the PI 4-kinase (PI4KIII), type I PIP 5-kinase (PIPKI), PI3K, Ras, PDK1 and Akt into the
scaffold. Remarkably, we show that IQGAP2 and IQGAP3 also assemble the PI 3-kinase pathway components
but with different outcomes. IQGAP2 is tumor suppressor in cancer cells whereas IQGAP1 and IQGAP3 promote
PI3K signaling and cell proliferation. Here, we will explore how receptors stimulate the assembly of the IQGAPs
signaling pathways with an emphasis on the EGF receptor and IQGAP1-PI 3-kinase and Erk pathways. We will
emphasize spatial PI 3-kinase signaling at endosomal compartments at proximity to microtubules by linkage with
microtubule associated protein 4 (MAP4) that interacts with IQGAP1 and PI 3-kinase. The link between the
cytosolic and nuclear PI signaling is the PIPKI, which generates PIP2 in the cytosol and nucleus
Nuclear PI signaling remarkably is not associated with membrane compartments. We showed that a nuclear
poly(A) polymerase, Star-PAP (for speckle targeted PIPKI regulated-poly(A) polymerase), associates with
PIPKI and is activated by phosphatidylinositol-4,5-bisphosphate (PIP2). Star-PAP controls ~40% of genes and
is regulated by many signals. Recently, we have shown that PIPKI also binds to the tumor suppressor p53,
and that p53 is a PIP2 effector. The binding of PIP2 stimulates p53’s interactions with other nuclear factors that
control p53 function. Both Star-PAP and p53 are also regulated by inositol polyphosphate multikinase (IPMK)
that generates phosphatidylinositol-3,4,5-trisphosphate (PIP3) associated with p53, and nuclear PTEN that
dephosphorylates this PIP3. We have identified Star-PAP and p53 as two key effectors of nuclear
phosphoinositide signaling during stress signaling. This proposal will focus on the mechanism and impact of this
stress pathway on Star-PAP functions. Remarkably the PIPn is so tightly associated with Star-PAP and p53 that
it is stable to SDS-PAGE suggesting a covalent linkage and we will explore how PIP2 is linked to Star-PAP and
p53. Is this covalent or a very tight interaction that is resistant to denaturation? Our findings indicate new avenues
for potential therapeutic control of both the cytosolic and nuclear PI pathways as these pathways have
fundamental implications in many disease processes but with an emphasis on cancer.
项目摘要。本研究旨在了解空间磷酸肌醇信号传导 (PI) 机制
这些途径对癌症、神经发育障碍、
糖尿病和一些先天性疾病在细胞质中,激动剂,例如 EGF(和许多其他),会被激活。
控制大多数细胞功能的信号通路 在细胞核中,这些通路与已知的通路是分开的。
膜隔室,但控制影响 DNA 修复、细胞存活和其他事件的应激反应。
激动剂激活的 PI3K 信号传导通过组装多个途径的 IQGAP1 支架发生
包括 PI 3 激酶和 Erk 通路,但 IQGAP 如何组装特定的信号通路尚不清楚。
我们将重点关注 IQGAP 上完整 PI 3 激酶途径的组装。
将 PI 4-激酶 (PI4KIII)、I 型 PIP 5-激酶 (PIPKI)、PI3K、Ras、PDK1 和 Akt 组装到
值得注意的是,我们表明 IQGAP2 和 IQGAP3 也组装 PI 3 激酶途径组件。
但 IQGAP2 是癌细胞的肿瘤抑制因子,而 IQGAP1 和 IQGAP3 则具有促进作用。
PI3K 信号传导和细胞增殖在这里,我们将探讨受体如何刺激 IQGAP 的组装。
我们将重点关注 EGF 受体和 IQGAP1-PI 3-激酶和 Erk 信号通路。
通过与微管附近的连接强调内体区室的空间 PI 3 激酶信号传导
微管相关蛋白 4 (MAP4) 与 IQGAP1 和 PI 3 激酶相互作用。
细胞质和细胞核 PI 信号传导是 PIPKI,它在细胞质和细胞核中生成 PIP2
核 PI 信号传导异常地与膜区室无关。
聚 (A) 聚合酶,Star-PAP(用于斑点靶向 PIPKI 调节聚 (A) 聚合酶),与
PIPKI 并由 4,5-二磷酸磷脂酰肌醇 (PIP2) 激活,Star-PAP 控制约 40% 的基因和
最近,我们发现 PIPKI 也与肿瘤抑制因子 p53 结合。
p53 是 PIP2 效应子 PIP2 的结合刺激 p53 与其他核因子的相互作用。
Star-PAP 和 p53 也受肌醇多磷酸激酶 (IPMK) 的调节。
产生与 p53 相关的磷脂酰肌醇-3,4,5-三磷酸 (PIP3) 和核 PTEN
我们已经确定 Star-PAP 和 p53 是核的两个关键效应子。
该提案将重点关注其机制和影响。
Star-PAP 功能的应激途径 值得注意的是,PIPn 与 Star-PAP 和 p53 密切相关。
它对 SDS-PAGE 稳定,表明存在共价连接,我们将探讨 PIP2 如何与 Star-PAP 连接并
p53. 这是共价还是非常紧密的相互作用,可以抵抗变性?
用于细胞质和核 PI 途径的潜在治疗控制,因为这些途径具有
对许多疾病过程有根本性影响,但重点是癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard A. Anderson其他文献
Nutritional role of chromium.
铬的营养作用。
- DOI:
10.1016/0048-9697(81)90104-2 - 发表时间:
1981-09-14 - 期刊:
- 影响因子:0
- 作者:
Richard A. Anderson - 通讯作者:
Richard A. Anderson
Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men.
性腺功能减退男性中合成雄激素 7 α-甲基-19-去甲睾酮的组织选择性的证据。
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:5.8
- 作者:
Richard A. Anderson;A. Michael Wallace;N. Sattar;Narendar Kumar;K. Sundaram - 通讯作者:
K. Sundaram
Interactions between protein 4.1 and band 3. An alternative binding site for an element of the membrane skeleton.
蛋白质 4.1 和带 3 之间的相互作用。膜骨架元件的替代结合位点。
- DOI:
- 发表时间:
1985 - 期刊:
- 影响因子:4.8
- 作者:
Gary R. PasternackS;Richard A. Anderson;Thomas L. Leto;Vincent T. Marchesi - 通讯作者:
Vincent T. Marchesi
Umbilical cord blood banking
脐带血库
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:0
- 作者:
Sapna Maheshwari;Marc L. Turner;Richard A. Anderson - 通讯作者:
Richard A. Anderson
Diethylstilboestrol Exposure Does Not Reduce Testosterone Production in Human Fetal Testis Xenografts
己烯雌酚暴露不会降低人类胎儿睾丸异种移植物中睾酮的产生
- DOI:
- 发表时间:
2013 - 期刊:
- 影响因子:3.7
- 作者:
R. Mitchell;R. M. Sharpe;Richard A. Anderson;C. Mckinnell;S. Macpherson;Lee B. Smith;W. Wallace;Christopher J. H. Kelnar;Sander van den Driesche - 通讯作者:
Sander van den Driesche
Richard A. Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard A. Anderson', 18)}}的其他基金
Tau-PI3Kalpha Complex in Regulation of PI3K/Akt-dependent Neuronal Function and Survival
Tau-PI3Kalpha 复合物调节 PI3K/Akt 依赖性神经元功能和存活
- 批准号:
10710161 - 财政年份:2022
- 资助金额:
$ 70.71万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10323007 - 财政年份:2020
- 资助金额:
$ 70.71万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10077869 - 财政年份:2020
- 资助金额:
$ 70.71万 - 项目类别:
Phosphoinositide Signaling in the Cytosol and Nucleus
细胞质和细胞核中的磷酸肌醇信号转导
- 批准号:
10386086 - 财政年份:2020
- 资助金额:
$ 70.71万 - 项目类别:
Administrative Supplement: Phosphoinositide Signaling in the Cytosol and Nucleus
行政补充:细胞质和细胞核中的磷酸肌醇信号传导
- 批准号:
10799130 - 财政年份:2020
- 资助金额:
$ 70.71万 - 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
- 批准号:
9027153 - 财政年份:2015
- 资助金额:
$ 70.71万 - 项目类别:
Nuclear Phosphoinositide Control of 3'-end mRNA Processing and Gene Expression
核磷酸肌醇控制 3 端 mRNA 加工和基因表达
- 批准号:
9199104 - 财政年份:2015
- 资助金额:
$ 70.71万 - 项目类别:
Phosphoinositide Signaling To and Within the Nucleus
进入细胞核和细胞核内的磷酸肌醇信号传导
- 批准号:
8059297 - 财政年份:2010
- 资助金额:
$ 70.71万 - 项目类别:
Graduate Training in Molecular and Cellular Pharmacology
分子和细胞药理学研究生培训
- 批准号:
7892114 - 财政年份:2009
- 资助金额:
$ 70.71万 - 项目类别:
PI Signaling Role in Epithelial/Mesenchymal Transition
PI 信号在上皮/间质转化中的作用
- 批准号:
7988327 - 财政年份:2004
- 资助金额:
$ 70.71万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
利用分子装订二硫键新策略优化改造α-芋螺毒素的研究
- 批准号:82104024
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CST蛋白复合体在端粒复制中对端粒酶移除与C链填补调控的分子机制研究
- 批准号:31900521
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
Wdr47蛋白在神经元极化中的功能及作用机理的研究
- 批准号:31900503
- 批准年份:2019
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
相似海外基金
The role of BET proteins in pathological cardiac remodeling
BET蛋白在病理性心脏重塑中的作用
- 批准号:
10538142 - 财政年份:2023
- 资助金额:
$ 70.71万 - 项目类别:
Discovery and development of GPR3 agonists for nicotine cessation
发现和开发用于戒烟的 GPR3 激动剂
- 批准号:
10825123 - 财政年份:2023
- 资助金额:
$ 70.71万 - 项目类别:
Investigating the Effects of ADGRB3 Signaling on Incretin-Mediated Insulin Secretion from Pancreatic Beta-Cells
研究 ADGRB3 信号传导对肠促胰素介导的胰腺 β 细胞胰岛素分泌的影响
- 批准号:
10666206 - 财政年份:2023
- 资助金额:
$ 70.71万 - 项目类别:
Estrogen, Astrocyte Reactivity, and Sex Differences in Alzheimer's Disease
阿尔茨海默病中的雌激素、星形胶质细胞反应性和性别差异
- 批准号:
10662993 - 财政年份:2023
- 资助金额:
$ 70.71万 - 项目类别: